PDB Short entry for 1H66 HEADER OXIDOREDUCTASE 06-JUN-01 1H66 TITLE CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE CO WITH TITLE 2 2,5-DIAZIRIDINYL-3-HYDROXYL-6-METHYL-1,4-BENZOQUINONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NAD(P)H DEHYDROGENASE [QUINONE] 1; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: QUINONE REDUCTASE 1, QR1, DT-DIAPHORASE, DTD, COMPND 5 AZOREDUCTASE, PHYLLOQUINONE REDUCTASE, MENADIONE REDUCTASE; COMPND 6 EC: 1.6.99.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS FLAVOPROTEIN, ROSSMANN FOLD, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR M.FAIG,M.A.BIANCHET,S.WINSKI,D.ROSS,L.M.AMZEL REVDAT 3 12-NOV-14 1H66 1 HEADER TITLE COMPND KEYWDS REVDAT 3 2 JRNL REMARK VERSN HETSYN REVDAT 3 3 FORMUL SHEET MASTER REVDAT 2 24-FEB-09 1H66 1 VERSN REVDAT 1 05-SEP-01 1H66 0 JRNL AUTH M.FAIG,M.A.BIANCHET,S.WINSKI,R.HARGREAVES,C.J.MOODY, JRNL AUTH 2 A.R.HUDNOTT,D.ROSS,L.M.AMZEL JRNL TITL STRUCTURE-BASED DEVELOPMENT OF ANTICANCER DRUGS: COMPLEXES JRNL TITL 2 OF NAD(P)H:QUINONE OXIDOREDUCTASE 1 WITH CHEMOTHERAPEUTIC JRNL TITL 3 QUINONES JRNL REF STRUCTURE V. 9 659 2001 JRNL REFN ISSN 0969-2126 JRNL PMID 11587640 JRNL DOI 10.1016/S0969-2126(01)00636-0 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.FAIG,M.A.BIANCHET,S.CHEN,S.WINSKI,D.ROSS,P.TALALAY, REMARK 1 AUTH 2 L.M.AMZEL REMARK 1 TITL STRUCTURES OF RECOMBINANT MOUSE AND HUMAN NAD(P)H:QUINONE REMARK 1 TITL 2 OXIDOREDUCTASES:SPECIES COMPARISON AND STRUCTURAL CHANGES REMARK 1 TITL 3 WITH SUBSTRATE BINDING AND RELEASE REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 97 3177 2000 REMARK 1 REFN ISSN 0027-8424 REMARK 1 PMID 10706635 REMARK 1 DOI 10.1073/PNAS.050585797 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.A.BIANCHET,C.FOSTER,M.FAIG,P.TALALAY,L.M.AMZEL REMARK 1 TITL STRUCTURE AND MECHANISM OF CYTOSOLIC QUINONE REDUCTASE REMARK 1 REF BIOCHEM.SOC.TRANS. V. 27 610 1999 REMARK 1 REFN ISSN 0300-5127 REMARK 1 PMID 10917652 REMARK 1 REFERENCE 3 REMARK 1 AUTH C.FOSTER,M.A.BIANCHET,P.TALALAY,Q.ZHAO,L.M.AMZEL REMARK 1 TITL CRYSTAL STRUCTURE OF HUMAN QUINONE REDUCTASE TYPE 2, A REMARK 1 TITL 2 METALLOPROTEIN REMARK 1 REF BIOCHEMISTRY V. 38 9881 1999 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 10433694 REMARK 1 DOI 10.1021/BI990799V REMARK 1 REFERENCE 4 REMARK 1 AUTH R.LI,M.A.BIANCHET,P.TALALAY,L.M.AMZEL REMARK 1 TITL THE THREE-DIMENSIONAL STRUCTURE OF NAD(P)H:QUINONE REMARK 1 TITL 2 REDUCTASE, A FLAVOPROTEIN INVOLVED IN CANCER REMARK 1 TITL 3 CHEMOPROTECTION AND CHEMOTHERAPY: MECHANISM OF TWO-ELECTRON REMARK 1 TITL 4 REDUCTION REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 92 8846 1995 REMARK 1 REFN ISSN 0027-8424 REMARK 1 PMID 7568029 REMARK 1 DOI 10.1073/PNAS.92.19.8846 REMARK 2 REMARK 2 RESOLUTION. 2.0 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.0 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 478391.80 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.000000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 73717 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.256 REMARK 3 FREE R VALUE : 0.199 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 90.0 REMARK 3 FREE R VALUE TEST SET COUNT : 66309 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.001 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.4 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1070 REMARK 3 BIN R VALUE (WORKING SET) : 0.301 REMARK 3 BIN FREE R VALUE : 0.273 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 90.2 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 9822 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.003 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8692 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 280 REMARK 3 SOLVENT ATOMS : 701 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 9.7 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.5 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.85 REMARK 3 B22 (A**2) : -2.92 REMARK 3 B33 (A**2) : 2.07 REMARK 3 B12 (A**2) : -1.64 REMARK 3 B13 (A**2) : 3.71 REMARK 3 B23 (A**2) : 2.37 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM SIGMAA (A) : 0.25 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.27 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.4 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.1 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.84 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.74 ; 1.50 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.31 ; 2.00 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.08 ; 2.00 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 1.74 ; 2.50 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.343615 REMARK 3 BSOL : 34.4807 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : RH1.PAR REMARK 3 PARAMETER FILE 3 : NEWFAD_XPLOR.PAR REMARK 3 PARAMETER FILE 4 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : ION.TOP REMARK 3 TOPOLOGY FILE 3 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 4 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 5 : WATER.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1H66 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-JUN-01. REMARK 100 THE PDBE ID CODE IS EBI-8156. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRANDEIS CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 73718 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 19.960 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -38.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9350 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21090 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -40.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 123 -48.10 77.93 REMARK 500 TYR A 132 -123.72 43.27 REMARK 500 SER A 191 57.08 33.44 REMARK 500 HIS A 257 56.43 -103.64 REMARK 500 LEU A 259 19.03 53.58 REMARK 500 LYS A 261 -168.60 -101.20 REMARK 500 ARG A 272 103.35 80.55 REMARK 500 GLU B 123 -50.25 80.88 REMARK 500 TYR B 132 -126.49 51.74 REMARK 500 PHE B 137 30.91 -97.24 REMARK 500 ILE B 175 -61.60 -101.31 REMARK 500 SER B 191 57.90 34.36 REMARK 500 LEU B 230 56.88 -67.31 REMARK 500 SER B 254 -170.22 -170.92 REMARK 500 HIS B 257 54.68 -108.92 REMARK 500 LYS B 261 -160.38 -113.92 REMARK 500 ARG B 272 98.80 79.80 REMARK 500 GLU C 123 -48.45 80.77 REMARK 500 TYR C 132 -116.00 38.56 REMARK 500 HIS C 257 54.09 -109.62 REMARK 500 LYS C 261 -169.85 -100.31 REMARK 500 ALA C 271 -154.01 -72.59 REMARK 500 ARG C 272 86.81 77.52 REMARK 500 GLU D 123 -42.40 80.87 REMARK 500 TYR D 132 -120.19 45.57 REMARK 500 SER D 191 56.35 31.86 REMARK 500 SER D 254 -168.99 -160.66 REMARK 500 HIS D 257 55.18 -109.08 REMARK 500 LEU D 259 17.52 50.39 REMARK 500 LYS D 261 -168.53 -109.58 REMARK 500 ARG D 272 92.13 92.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RH1 A1274 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD A1275 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RH1 B1274 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD B1275 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RH1 C1274 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD C1275 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RH1 D1274 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD D1275 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1D4A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE REMARK 900 OXIDOREDUCTASE AT 1.7 A RESOLUTION REMARK 900 RELATED ID: 1DXO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE REMARK 900 OXIDOREDUCTASE CO WITH 2,3,5,6, REMARK 900 TETRAMETHYL-P-BENZOQUINONE (DUROQUINONE) AT 2. REMARK 900 RELATED ID: 1QBG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN DT-DIAPHORASE REMARK 900 (NAD(P)H OXIDOREDUCTASE) REMARK 900 RELATED ID: 1H69 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE REMARK 900 OXIDOREDUCTASE CO WITH 2,3,5,6, REMARK 900 TETRAMETHYL-P-BENZOQUINONE (DUROQUINONE) AT 2.5 REMARK 900 ANGSTROM RESOLUTION DBREF 1H66 A 1 273 UNP P15559 DHQU_HUMAN 2 274 DBREF 1H66 B 1 273 UNP P15559 DHQU_HUMAN 2 274 DBREF 1H66 C 1 273 UNP P15559 DHQU_HUMAN 2 274 DBREF 1H66 D 1 273 UNP P15559 DHQU_HUMAN 2 274 SEQADV 1H66 ALA A 1 UNP P15559 VAL 2 CONFLICT SEQADV 1H66 ALA B 1 UNP P15559 VAL 2 CONFLICT SEQADV 1H66 ALA C 1 UNP P15559 VAL 2 CONFLICT SEQADV 1H66 ALA D 1 UNP P15559 VAL 2 CONFLICT SEQRES 1 A 273 ALA GLY ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU SEQRES 2 A 273 ARG THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA ALA SEQRES 3 A 273 ALA ALA LEU LYS LYS LYS GLY TRP GLU VAL VAL GLU SER SEQRES 4 A 273 ASP LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG SEQRES 5 A 273 LYS ASP ILE THR GLY LYS LEU LYS ASP PRO ALA ASN PHE SEQRES 6 A 273 GLN TYR PRO ALA GLU SER VAL LEU ALA TYR LYS GLU GLY SEQRES 7 A 273 HIS LEU SER PRO ASP ILE VAL ALA GLU GLN LYS LYS LEU SEQRES 8 A 273 GLU ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN SEQRES 9 A 273 TRP PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU SEQRES 10 A 273 ARG VAL PHE ILE GLY GLU PHE ALA TYR THR TYR ALA ALA SEQRES 11 A 273 MET TYR ASP LYS GLY PRO PHE ARG SER LYS LYS ALA VAL SEQRES 12 A 273 LEU SER ILE THR THR GLY GLY SER GLY SER MET TYR SER SEQRES 13 A 273 LEU GLN GLY ILE HIS GLY ASP MET ASN VAL ILE LEU TRP SEQRES 14 A 273 PRO ILE GLN SER GLY ILE LEU HIS PHE CYS GLY PHE GLN SEQRES 15 A 273 VAL LEU GLU PRO GLN LEU THR TYR SER ILE GLY HIS THR SEQRES 16 A 273 PRO ALA ASP ALA ARG ILE GLN ILE LEU GLU GLY TRP LYS SEQRES 17 A 273 LYS ARG LEU GLU ASN ILE TRP ASP GLU THR PRO LEU TYR SEQRES 18 A 273 PHE ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA SEQRES 19 A 273 GLY PHE LEU MET LYS LYS GLU VAL GLN ASP GLU GLU LYS SEQRES 20 A 273 ASN LYS LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY SEQRES 21 A 273 LYS SER ILE PRO THR ASP ASN GLN ILE LYS ALA ARG LYS SEQRES 1 B 273 ALA GLY ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU SEQRES 2 B 273 ARG THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA ALA SEQRES 3 B 273 ALA ALA LEU LYS LYS LYS GLY TRP GLU VAL VAL GLU SER SEQRES 4 B 273 ASP LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG SEQRES 5 B 273 LYS ASP ILE THR GLY LYS LEU LYS ASP PRO ALA ASN PHE SEQRES 6 B 273 GLN TYR PRO ALA GLU SER VAL LEU ALA TYR LYS GLU GLY SEQRES 7 B 273 HIS LEU SER PRO ASP ILE VAL ALA GLU GLN LYS LYS LEU SEQRES 8 B 273 GLU ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN SEQRES 9 B 273 TRP PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU SEQRES 10 B 273 ARG VAL PHE ILE GLY GLU PHE ALA TYR THR TYR ALA ALA SEQRES 11 B 273 MET TYR ASP LYS GLY PRO PHE ARG SER LYS LYS ALA VAL SEQRES 12 B 273 LEU SER ILE THR THR GLY GLY SER GLY SER MET TYR SER SEQRES 13 B 273 LEU GLN GLY ILE HIS GLY ASP MET ASN VAL ILE LEU TRP SEQRES 14 B 273 PRO ILE GLN SER GLY ILE LEU HIS PHE CYS GLY PHE GLN SEQRES 15 B 273 VAL LEU GLU PRO GLN LEU THR TYR SER ILE GLY HIS THR SEQRES 16 B 273 PRO ALA ASP ALA ARG ILE GLN ILE LEU GLU GLY TRP LYS SEQRES 17 B 273 LYS ARG LEU GLU ASN ILE TRP ASP GLU THR PRO LEU TYR SEQRES 18 B 273 PHE ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA SEQRES 19 B 273 GLY PHE LEU MET LYS LYS GLU VAL GLN ASP GLU GLU LYS SEQRES 20 B 273 ASN LYS LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY SEQRES 21 B 273 LYS SER ILE PRO THR ASP ASN GLN ILE LYS ALA ARG LYS SEQRES 1 C 273 ALA GLY ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU SEQRES 2 C 273 ARG THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA ALA SEQRES 3 C 273 ALA ALA LEU LYS LYS LYS GLY TRP GLU VAL VAL GLU SER SEQRES 4 C 273 ASP LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG SEQRES 5 C 273 LYS ASP ILE THR GLY LYS LEU LYS ASP PRO ALA ASN PHE SEQRES 6 C 273 GLN TYR PRO ALA GLU SER VAL LEU ALA TYR LYS GLU GLY SEQRES 7 C 273 HIS LEU SER PRO ASP ILE VAL ALA GLU GLN LYS LYS LEU SEQRES 8 C 273 GLU ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN SEQRES 9 C 273 TRP PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU SEQRES 10 C 273 ARG VAL PHE ILE GLY GLU PHE ALA TYR THR TYR ALA ALA SEQRES 11 C 273 MET TYR ASP LYS GLY PRO PHE ARG SER LYS LYS ALA VAL SEQRES 12 C 273 LEU SER ILE THR THR GLY GLY SER GLY SER MET TYR SER SEQRES 13 C 273 LEU GLN GLY ILE HIS GLY ASP MET ASN VAL ILE LEU TRP SEQRES 14 C 273 PRO ILE GLN SER GLY ILE LEU HIS PHE CYS GLY PHE GLN SEQRES 15 C 273 VAL LEU GLU PRO GLN LEU THR TYR SER ILE GLY HIS THR SEQRES 16 C 273 PRO ALA ASP ALA ARG ILE GLN ILE LEU GLU GLY TRP LYS SEQRES 17 C 273 LYS ARG LEU GLU ASN ILE TRP ASP GLU THR PRO LEU TYR SEQRES 18 C 273 PHE ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA SEQRES 19 C 273 GLY PHE LEU MET LYS LYS GLU VAL GLN ASP GLU GLU LYS SEQRES 20 C 273 ASN LYS LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY SEQRES 21 C 273 LYS SER ILE PRO THR ASP ASN GLN ILE LYS ALA ARG LYS SEQRES 1 D 273 ALA GLY ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU SEQRES 2 D 273 ARG THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA ALA SEQRES 3 D 273 ALA ALA LEU LYS LYS LYS GLY TRP GLU VAL VAL GLU SER SEQRES 4 D 273 ASP LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG SEQRES 5 D 273 LYS ASP ILE THR GLY LYS LEU LYS ASP PRO ALA ASN PHE SEQRES 6 D 273 GLN TYR PRO ALA GLU SER VAL LEU ALA TYR LYS GLU GLY SEQRES 7 D 273 HIS LEU SER PRO ASP ILE VAL ALA GLU GLN LYS LYS LEU SEQRES 8 D 273 GLU ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN SEQRES 9 D 273 TRP PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU SEQRES 10 D 273 ARG VAL PHE ILE GLY GLU PHE ALA TYR THR TYR ALA ALA SEQRES 11 D 273 MET TYR ASP LYS GLY PRO PHE ARG SER LYS LYS ALA VAL SEQRES 12 D 273 LEU SER ILE THR THR GLY GLY SER GLY SER MET TYR SER SEQRES 13 D 273 LEU GLN GLY ILE HIS GLY ASP MET ASN VAL ILE LEU TRP SEQRES 14 D 273 PRO ILE GLN SER GLY ILE LEU HIS PHE CYS GLY PHE GLN SEQRES 15 D 273 VAL LEU GLU PRO GLN LEU THR TYR SER ILE GLY HIS THR SEQRES 16 D 273 PRO ALA ASP ALA ARG ILE GLN ILE LEU GLU GLY TRP LYS SEQRES 17 D 273 LYS ARG LEU GLU ASN ILE TRP ASP GLU THR PRO LEU TYR SEQRES 18 D 273 PHE ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA SEQRES 19 D 273 GLY PHE LEU MET LYS LYS GLU VAL GLN ASP GLU GLU LYS SEQRES 20 D 273 ASN LYS LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY SEQRES 21 D 273 LYS SER ILE PRO THR ASP ASN GLN ILE LYS ALA ARG LYS HET RH1 A1274 17 HET FAD A1275 53 HET RH1 B1274 17 HET FAD B1275 53 HET RH1 C1274 17 HET FAD C1275 53 HET RH1 D1274 17 HET FAD D1275 53 HETNAM RH1 2,5-DIAZIRIDIN-1-YL-3-(HYDROXYMETHYL)-6- HETNAM 2 RH1 METHYLCYCLOHEXA-2,5-DIENE-1,4-DIONE HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE FORMUL 5 RH1 4(C12 H14 N2 O3) FORMUL 6 FAD 4(C27 H33 N9 O15 P2) FORMUL 13 HOH *701(H2 O) HELIX 1 1 SER A 16 LYS A 32 1 17 HELIX 2 2 SER A 51 ASP A 54 5 4 HELIX 3 3 GLN A 66 GLY A 78 1 13 HELIX 4 4 SER A 81 ALA A 94 1 14 HELIX 5 5 PRO A 109 PHE A 120 1 12 HELIX 6 6 MET A 131 GLY A 135 5 5 HELIX 7 7 SER A 151 SER A 156 5 6 HELIX 8 8 ASP A 163 SER A 173 1 11 HELIX 9 9 LEU A 176 GLY A 180 5 5 HELIX 10 10 SER A 191 THR A 195 5 5 HELIX 11 11 PRO A 196 LEU A 211 1 16 HELIX 12 12 GLU A 212 GLU A 217 5 6 HELIX 13 13 PRO A 224 LEU A 227 5 4 HELIX 14 14 ASN A 231 GLY A 235 5 5 HELIX 15 15 LYS A 239 LYS A 247 1 9 HELIX 16 16 SER B 16 LYS B 32 1 17 HELIX 17 17 SER B 51 ASP B 54 5 4 HELIX 18 18 GLN B 66 GLY B 78 1 13 HELIX 19 19 SER B 81 ALA B 94 1 14 HELIX 20 20 PRO B 109 PHE B 120 1 12 HELIX 21 21 THR B 127 MET B 131 5 5 HELIX 22 22 MET B 131 GLY B 135 5 5 HELIX 23 23 SER B 151 SER B 156 5 6 HELIX 24 24 ASP B 163 SER B 173 1 11 HELIX 25 25 LEU B 176 GLY B 180 5 5 HELIX 26 26 SER B 191 THR B 195 5 5 HELIX 27 27 PRO B 196 GLU B 212 1 17 HELIX 28 28 ASN B 213 GLU B 217 5 5 HELIX 29 29 PRO B 224 LEU B 227 5 4 HELIX 30 30 LYS B 239 LYS B 247 1 9 HELIX 31 31 SER C 16 LYS C 32 1 17 HELIX 32 32 SER C 51 ASP C 54 5 4 HELIX 33 33 GLN C 66 GLY C 78 1 13 HELIX 34 34 SER C 81 ALA C 94 1 14 HELIX 35 35 PRO C 109 PHE C 120 1 12 HELIX 36 36 THR C 127 MET C 131 5 5 HELIX 37 37 MET C 131 GLY C 135 5 5 HELIX 38 38 SER C 151 SER C 156 5 6 HELIX 39 39 ASP C 163 SER C 173 1 11 HELIX 40 40 LEU C 176 GLY C 180 5 5 HELIX 41 41 SER C 191 THR C 195 5 5 HELIX 42 42 PRO C 196 LEU C 211 1 16 HELIX 43 43 GLU C 212 GLU C 217 5 6 HELIX 44 44 PRO C 224 LEU C 227 5 4 HELIX 45 45 LYS C 239 LYS C 247 1 9 HELIX 46 46 SER D 16 LYS D 32 1 17 HELIX 47 47 SER D 51 ASP D 54 5 4 HELIX 48 48 ASP D 61 PHE D 65 5 5 HELIX 49 49 GLN D 66 GLY D 78 1 13 HELIX 50 50 SER D 81 ALA D 94 1 14 HELIX 51 51 PRO D 109 PHE D 120 1 12 HELIX 52 52 THR D 127 MET D 131 5 5 HELIX 53 53 MET D 131 GLY D 135 5 5 HELIX 54 54 SER D 151 SER D 156 5 6 HELIX 55 55 ASP D 163 SER D 173 1 11 HELIX 56 56 LEU D 176 GLY D 180 5 5 HELIX 57 57 SER D 191 THR D 195 5 5 HELIX 58 58 PRO D 196 GLU D 212 1 17 HELIX 59 59 ASN D 213 GLU D 217 5 5 HELIX 60 60 PRO D 224 LEU D 227 5 4 HELIX 61 61 LYS D 239 LYS D 247 1 9 SHEET 1 AA 5 GLU A 35 ASP A 40 0 SHEET 2 AA 5 ARG A 4 LEU A 9 1 O ALA A 5 N VAL A 37 SHEET 3 AA 5 LEU A 96 PRO A 102 1 O LEU A 96 N LEU A 6 SHEET 4 AA 5 LYS A 141 THR A 147 1 O LYS A 141 N VAL A 97 SHEET 5 AA 5 GLN A 187 THR A 189 -1 O GLN A 187 N ILE A 146 SHEET 1 AB 5 GLU A 35 ASP A 40 0 SHEET 2 AB 5 ARG A 4 LEU A 9 1 O ALA A 5 N VAL A 37 SHEET 3 AB 5 LEU A 96 PRO A 102 1 O LEU A 96 N LEU A 6 SHEET 4 AB 5 LYS A 141 THR A 147 1 O LYS A 141 N VAL A 97 SHEET 5 AB 5 GLN A 182 VAL A 183 1 O GLN A 182 N ALA A 142 SHEET 1 AC 2 GLN A 187 THR A 189 0 SHEET 2 AC 2 LYS A 141 THR A 147 -1 O LEU A 144 N GLN A 187 SHEET 1 BA 5 GLU B 35 ASP B 40 0 SHEET 2 BA 5 ARG B 4 LEU B 9 1 O ALA B 5 N VAL B 37 SHEET 3 BA 5 LEU B 96 PRO B 102 1 O LEU B 96 N LEU B 6 SHEET 4 BA 5 LYS B 141 THR B 147 1 O LYS B 141 N VAL B 97 SHEET 5 BA 5 GLN B 187 THR B 189 -1 O GLN B 187 N ILE B 146 SHEET 1 BB 5 GLU B 35 ASP B 40 0 SHEET 2 BB 5 ARG B 4 LEU B 9 1 O ALA B 5 N VAL B 37 SHEET 3 BB 5 LEU B 96 PRO B 102 1 O LEU B 96 N LEU B 6 SHEET 4 BB 5 LYS B 141 THR B 147 1 O LYS B 141 N VAL B 97 SHEET 5 BB 5 GLN B 182 VAL B 183 1 O GLN B 182 N ALA B 142 SHEET 1 BC 2 GLN B 187 THR B 189 0 SHEET 2 BC 2 LYS B 141 THR B 147 -1 O LEU B 144 N GLN B 187 SHEET 1 CA 5 GLU C 35 ASP C 40 0 SHEET 2 CA 5 ARG C 4 LEU C 9 1 O ALA C 5 N VAL C 37 SHEET 3 CA 5 LEU C 96 PRO C 102 1 O LEU C 96 N LEU C 6 SHEET 4 CA 5 LYS C 141 THR C 147 1 O LYS C 141 N VAL C 97 SHEET 5 CA 5 GLN C 187 THR C 189 -1 O GLN C 187 N ILE C 146 SHEET 1 CB 5 GLU C 35 ASP C 40 0 SHEET 2 CB 5 ARG C 4 LEU C 9 1 O ALA C 5 N VAL C 37 SHEET 3 CB 5 LEU C 96 PRO C 102 1 O LEU C 96 N LEU C 6 SHEET 4 CB 5 LYS C 141 THR C 147 1 O LYS C 141 N VAL C 97 SHEET 5 CB 5 GLN C 182 VAL C 183 1 O GLN C 182 N ALA C 142 SHEET 1 CC 2 GLN C 187 THR C 189 0 SHEET 2 CC 2 LYS C 141 THR C 147 -1 O LEU C 144 N GLN C 187 SHEET 1 DA 5 GLU D 35 ASP D 40 0 SHEET 2 DA 5 ARG D 4 LEU D 9 1 O ALA D 5 N VAL D 37 SHEET 3 DA 5 LEU D 96 PRO D 102 1 O LEU D 96 N LEU D 6 SHEET 4 DA 5 LYS D 141 THR D 147 1 O LYS D 141 N VAL D 97 SHEET 5 DA 5 GLN D 187 THR D 189 -1 O GLN D 187 N ILE D 146 SHEET 1 DB 5 GLU D 35 ASP D 40 0 SHEET 2 DB 5 ARG D 4 LEU D 9 1 O ALA D 5 N VAL D 37 SHEET 3 DB 5 LEU D 96 PRO D 102 1 O LEU D 96 N LEU D 6 SHEET 4 DB 5 LYS D 141 THR D 147 1 O LYS D 141 N VAL D 97 SHEET 5 DB 5 GLN D 182 VAL D 183 1 O GLN D 182 N ALA D 142 SHEET 1 DC 2 GLN D 187 THR D 189 0 SHEET 2 DC 2 LYS D 141 THR D 147 -1 O LEU D 144 N GLN D 187 SITE 1 AC1 8 TYR A 126 TYR A 128 PHE A 178 GLY C 149 SITE 2 AC1 8 GLY C 150 MET C 154 HIS C 161 FAD C1275 SITE 1 AC2 24 HIS A 11 THR A 15 SER A 16 PHE A 17 SITE 2 AC2 24 ASN A 18 ALA A 20 PRO A 102 LEU A 103 SITE 3 AC2 24 GLN A 104 TRP A 105 PHE A 106 THR A 147 SITE 4 AC2 24 THR A 148 GLY A 149 GLY A 150 TYR A 155 SITE 5 AC2 24 ILE A 192 ARG A 200 LEU A 204 HOH A2170 SITE 6 AC2 24 HOH A2171 GLN C 66 TYR C 67 RH1 C1274 SITE 1 AC3 8 TYR B 126 TYR B 128 PHE B 178 GLY D 149 SITE 2 AC3 8 GLY D 150 MET D 154 HIS D 161 FAD D1275 SITE 1 AC4 25 HIS B 11 THR B 15 SER B 16 PHE B 17 SITE 2 AC4 25 ASN B 18 ALA B 20 PRO B 102 LEU B 103 SITE 3 AC4 25 GLN B 104 TRP B 105 PHE B 106 THR B 147 SITE 4 AC4 25 THR B 148 GLY B 149 GLY B 150 TYR B 155 SITE 5 AC4 25 ILE B 192 ARG B 200 LEU B 204 HOH B2195 SITE 6 AC4 25 HOH B2196 HOH B2197 HOH B2198 GLN D 66 SITE 7 AC4 25 RH1 D1274 SITE 1 AC5 9 GLY A 149 GLY A 150 MET A 154 HIS A 161 SITE 2 AC5 9 FAD A1275 HOH A2170 TYR C 126 TYR C 128 SITE 3 AC5 9 PHE C 178 SITE 1 AC6 25 ILE A 50 GLN A 66 TYR A 67 RH1 A1274 SITE 2 AC6 25 HIS C 11 THR C 15 SER C 16 PHE C 17 SITE 3 AC6 25 ASN C 18 ALA C 20 PRO C 102 LEU C 103 SITE 4 AC6 25 GLN C 104 TRP C 105 PHE C 106 THR C 147 SITE 5 AC6 25 THR C 148 GLY C 149 GLY C 150 TYR C 155 SITE 6 AC6 25 ILE C 192 ARG C 200 LEU C 204 HOH C2130 SITE 7 AC6 25 HOH C2132 SITE 1 AC7 11 TRP B 105 PHE B 106 GLY B 149 GLY B 150 SITE 2 AC7 11 MET B 154 HIS B 161 FAD B1275 TYR D 126 SITE 3 AC7 11 TYR D 128 PHE D 178 HOH D2192 SITE 1 AC8 27 ILE B 50 GLN B 66 TYR B 67 PRO B 68 SITE 2 AC8 27 RH1 B1274 HIS D 11 THR D 15 SER D 16 SITE 3 AC8 27 PHE D 17 ASN D 18 ALA D 20 PRO D 102 SITE 4 AC8 27 LEU D 103 GLN D 104 TRP D 105 PHE D 106 SITE 5 AC8 27 THR D 147 THR D 148 GLY D 149 GLY D 150 SITE 6 AC8 27 TYR D 155 ILE D 192 ARG D 200 LEU D 204 SITE 7 AC8 27 HOH D2193 HOH D2194 HOH D2195 CRYST1 56.185 57.080 97.323 77.05 77.07 87.22 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017798 -0.000864 -0.003994 0.00000 SCALE2 0.000000 0.017540 -0.003938 0.00000 SCALE3 0.000000 0.000000 0.010805 0.00000